Tratamiento del cuello no en el cáncer supraglótico

treatment in pN0 patients showed a neck recurrence of 6,1%. We performed a unilateral neck dissection in those patients with clear-lateral tumours. In these cases the clinical control of the contralateral neck gave a 5,5% recurrencies on that side. Patients treated with elective primary radiotherapy suffered a 5,5% of regional recurrence. Discussion/Conclusions: Neck treatment of the N0 supraglottic cancer is recommended. We treat neck in the same way of primary tumour (surgery or radiotherapy) with good control of regional recurrencies, less than 10%. In case of a negative pathological study of the neck careful, watching is the elective attitude. In the positive pathological study of the neck (pN+), radiotherapy is the elective treatment in those with three or more affected nodes or capsular breakdown in any of them.